BridgeBio Pharma (BBIO) EBIT (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.08% |
| Dec 31, 2025 | 3.88% |
| Sep 30, 2025 | -8.13% |
| Jun 30, 2025 | -28.65% |
| Mar 31, 2025 | 53.82% |
| Dec 31, 2024 | -17.88% |
| Sep 30, 2024 | -9.23% |
| Jun 30, 2024 | -51,277.55% |
| Mar 31, 2024 | 100.19% |
| Dec 31, 2023 | -12.51% |
| Sep 30, 2023 | -7.94% |
| Jun 30, 2023 | -15.80% |
| Mar 31, 2023 | 2.37% |
| Dec 31, 2022 | -0.09% |
| Sep 30, 2022 | -61.04% |
| Jun 30, 2022 | 53.84% |
| Mar 31, 2022 | -4.87% |
| Dec 31, 2021 | -10.78% |
| Sep 30, 2021 | -59.02% |
| Jun 30, 2021 | 43.87% |
| Mar 31, 2021 | -31.39% |
| Dec 31, 2020 | -6.29% |
| Sep 30, 2020 | 3.72% |
| Jun 30, 2020 | -21.54% |
| Mar 31, 2020 | -30.33% |
| Dec 31, 2019 | -44.21% |
| Sep 30, 2019 | 21.33% |
| Jun 30, 2019 | -8.73% |
| Mar 31, 2019 | 2.79% |
| Dec 31, 2018 | -58.20% |
| Sep 30, 2018 | -19.18% |